Tilray Inc (TLRY) stock news · rev $915.5M
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This TLRY news page leads with what Tilray Inc filed — not a scraped headline mill.
No cached 8-K sentence for TLRY yet. We will not pad this page with generic market recap.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TLRY stock page; for the tape open the quote page.
TLRY stock news FAQ
What are TLRY's latest revenue and net income?
Latest cached Tilray Inc (TLRY) revenue for May 31, 2026 was $915.5M. Net income was -$121.4M. Statements: https://lician.com/financials/tlry
How did TLRY revenue change from the prior cached period?
Cached Tilray Inc (TLRY) revenue was up 11.5% from $821.3M (May 31, 2025) to $915.5M (May 31, 2026). Statements: https://lician.com/financials/tlry
What is TLRY's market cap?
Tilray Inc (TLRY) market cap is $573.9M on the latest cached fundamentals snapshot.
What kind of company is TLRY?
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Where is TLRY stock news listed?
Cached stock news for Tilray Inc (TLRY) is listed at https://lician.com/news/tlry. Filings: https://lician.com/sec/tlry
Not investment advice.